MedTrace Logo

Retinal Therapy Guided by 3D OCT Image Analysis

NCT02308215 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2019-08-30

No results posted yet for this study

Summary

The main purpose is to find a better way to predict the timing of treatments given to patients with Wet Age-related macular degeneration using image analysis.

Conditions

  • Age-Related Macular Degeneration
  • Choroidal Neovascularization

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Michael Abramoff

    lead OTHER

Principal Investigators

  • Michael D Abramoff, MD, PhD · University of Iowa

  • Milan Sonka, MS, PhD · University of Iowa

Eligibility

Min Age
45 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2018-07-05
Completion
2018-07-05

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308215 on ClinicalTrials.gov